Home › Triple-Negative Breast Cancer › Florida › Orlando
Triple-Negative Breast Cancer clinical trials in Orlando, FL
12 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- AdventHealth Cancer Institute, Orlando
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Orlando Health Cancer Institute ( Site 0030), Orlando
- AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs · 9 mi away
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
RecruitingPhase 3
- Orlando Health Cancer Institute ( Site 0012), Orlando
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs · 9 mi away
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs · 9 mi away
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- Sara Cannon Research Institute Lake Nona, Orlando
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
RecruitingPhase 1
- Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Advent Health, Orlando
SMP-3124LP in Adults With Advanced Solid Tumors
RecruitingPhase 1/2
- Advent Health, Celebration · 17 mi away
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Study of XB010 in Subjects With Solid Tumors
RecruitingPhase 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Orlando
Triple-Negative Breast Cancer trials in other cities
- Houston, TX41 studies
- New York City, NY31 studies
- Los Angeles, CA27 studies
- Nashville, TN27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- Arlington, VA20 studies
- Atlanta, GA19 studies
- St. Louis, MO19 studies
- Dallas, TX18 studies
- Columbus, OH16 studies
- Chicago, IL16 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity29 studies
- Metastatic Cancer29 studies
- Alzheimer's Disease25 studies
- Cancer (all types)25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.